4.6 Article

Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles

Journal

CELLULAR SIGNALLING
Volume 23, Issue 11, Pages 1767-1776

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2011.06.011

Keywords

AT(1) receptor; AT(2) receptor; Homomerization; Heteromerization; Protein-fragment complementation assay; GPCR-HIT

Categories

Funding

  1. National Health and Medical Research Council of Australia
  2. Australian Research Council [FT100100271]
  3. National Heart Foundation of Australia
  4. Wenkart Foundation
  5. Australian Postgraduate Award
  6. Baker Foundation
  7. Australian Research Council [FT100100271] Funding Source: Australian Research Council

Ask authors/readers for more resources

The cardiovascular hormone angiotensin II (AngII) exerts its actions via two G protein-coupled receptor (GPCR) subtypes, AT(1) and AT(2), which often display antagonistic functions. Methodological constraints have so far precluded detailed analyses of the ligand-dependency, cellular localization, and functional relevance of AngII receptor interactions in live cells. In this study, we utilize a protein-fragment complementation assay (PCA) and GPCR-Heteromer Identification Technology (GPCR-HIT) to provide the first detailed investigation of the ligand-dependency and cellular localization of AngII receptor interactions in human embryonic kidney 293 cells. Fluorescent-tagged receptor constructs for PCA and GPCR-HIT displayed normal affinity and selectivity for AngII (AT(1): IC50 = 1.0-1.6 nM; AT(2): IC50 = 2.0-3.0 nM). Well-characterized angiotensin receptor interactions were used as positive and negative controls to demonstrate the sensitivity and specificity of these fluorescence-based assays. We report that AT(1)-AT(2) receptor heteromers form constitutively, are localized to the plasma membrane and perinuclear compartments, and do not internalize following AngII stimulation despite arrestin being recruited specifically to the heteromer. Our findings using novel fluorescence-based technologies reveal a previously unrecognized mechanism of angiotensin receptor cross-talk involving cross-inhibition of AT(1) receptor internalization through heteromerization with the AT(2) receptor subtype. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available